Regional Access Manager |
Field Force (England / Wales) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
28 June 2024 |
VP Acct Mgmt and Pricing Strategy - (2 positions) |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
27 June 2024 |
Regional Access Manager, Lancashire & South Cumbria Humber, Coast & Vale South Yorkshire & Bassetlaw |
Field Force (England / Wales) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
21 June 2024 |
Regional Dir, Access & Reimbursement RLT - Remote - Central |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
21 June 2024 |
Strategy & HSS Sr. Manager |
Ramallo (Argentina) |
Argentina |
International |
Innovative Medicines |
Market Access |
21 June 2024 |
KAM |
Ramallo (Argentina) |
Argentina |
International |
Innovative Medicines |
Market Access |
21 June 2024 |
Market Access Specialist |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Market Access |
21 June 2024 |
AD, Access & Reimbursement NPS Radioligand Therapy Remote - Seattle WA |
Seattle, WA |
USA |
US |
Novartis Patient Support |
Market Access |
20 June 2024 |
Access and HEOR Lead |
Santo Amaro |
Brazil |
International |
Innovative Medicines |
Market Access |
20 June 2024 |
AD, Access & Reimbursement- Lancaster, PA |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
14 June 2024 |
Director, Case Management (3 Openings) |
East Hanover |
USA |
US |
Innovative Medicines |
Market Access |
14 June 2024 |
Regional Access and Solutions Manager |
Bucuresti |
Romania |
International |
Innovative Medicines |
Market Access |
13 June 2024 |
Pricing Manager |
Sydney |
Australia |
International |
APMA IMI |
Market Access |
06 June 2024 |
AD, Access & Reimbursement Radioligand Therapy Remote Salt Lake City |
Salt Lake City, UT |
USA |
US |
Novartis Patient Support |
Market Access |
04 June 2024 |
Head, Private Payers |
Field Non-Sales (Canada) |
Canada |
International |
Innovative Medicines |
Market Access |
03 June 2024 |
Head, Payeurs du secteur privé |
Field Non-Sales (Canada) |
Canada |
International |
Innovative Medicines |
Market Access |
03 June 2024 |
Lead/Associate, Field Access Management |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Market Access |
30 May 2024 |
Director, US Market Access TA Strategy Hematology |
East Hanover |
USA |
US |
Innovative Medicines |
Market Access |
29 May 2024 |
Director, Market Access Strategy - Remote (1 of 2 roles) |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
28 May 2024 |
Reimbursement Specialist I (10 am - 7 pm EST) - Multiple Positions |
Arizona |
USA |
US |
Innovative Medicines |
Market Access |
28 May 2024 |
Territory Account Manager |
Samara |
Russian Fed. |
International |
Innovative Medicines |
Market Access |
27 May 2024 |
AD, Access & Reimbursement Radioligand Therapy - Remote - Arkansas |
Little Rock, AR |
USA |
US |
Novartis Patient Support |
Market Access |
23 May 2024 |
Real World Evidence Team Lead |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Operations |
CTS |
Market Access |
13 May 2024 |
Healthcare partnership manager |
Moscow (City) |
Russian Fed. |
International |
Innovative Medicines |
Market Access |
13 May 2024 |
Territory Market Access Manager (Moscow, Central Region) |
Moscow (City) |
Russian Fed. |
International |
Innovative Medicines |
Market Access |
13 May 2024 |
Senior Patient Access Lead |
Estonia |
Estonia |
International |
Innovative Medicines |
Market Access |
18 April 2024 |
Senior Patient Access Lead |
Lithuania |
Lithuania |
International |
Innovative Medicines |
Market Access |
18 April 2024 |
Patient Access Lead |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
16 April 2024 |
New Products & Strategic Pricing Partner |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
16 April 2024 |
AD, Access & Reimbursement Radioligand Therapy-Remote-Miami /Bilingual |
Miami, FL |
USA |
US |
Novartis Patient Support |
Market Access |
28 March 2024 |